Continued here: QIAGEN reports results for Q1 2024 ahead of outlook, on track to achieve full-year 2024 guidance
Continued here: QIAGEN reports results for Q1 2024 ahead of outlook, on track to achieve full-year 2024 guidance
Go here to read the rest: Inotiv, Inc. to Report Fiscal 2024 Second Quarter Financial Results and Host Conference Call on Friday, May 10, 2024
Original post: Terns Pharmaceuticals Announces Data from Ongoing Phase 1 Pharmacokinetic Study of Allosteric BCR-ABL Inhibitor TERN-701 in Adult Healthy Volunteers...
See the article here: ACELYRIN, INC. to Report First Quarter 2024 Financial Results and Corporate Update on May 13, 2024
Continued here: Better Choice Company Announces Notification of Noncompliance with Additional NYSE American Continued Listing Standards
Read more from the original source: Travere Therapeutics to Report First Quarter 2024 Financial Results
Read the rest here: Cellectis Reports Financial Results for the Fourth Quarter and Full Year 2023
Go here to see the original: BeyondSpring Provides Business Update and Reports Year End 2023 Financial Results
See the original post here: BeyondSpring Files 2023 Annual Report on Form 20-F
Recent Comments